Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.

@article{Castillo2010PrognosticFI,
  title={Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.},
  author={Jorge J Castillo and E. Samuel Winer and Dariusz Stachurski and Kimberly Diaz Perez and Melhem Jabbour and Cannon Milani and Gerald A. Colvin and James N. Butera},
  journal={The oncologist},
  year={2010},
  volume={15 3},
  pages={293-9}
}
BACKGROUND Plasmablastic lymphoma (PBL) is a variant of diffuse large B-cell lymphoma commonly seen in the oral cavity of HIV-infected individuals. PBL has a poor prognosis, but prognostic factors in patients who have received chemotherapy have not been adequately evaluated. METHODS An extensive literature search rendered 248 cases of PBL, from which 157 were HIV(+). Seventy cases with HIV-associated PBL that received chemotherapy were identified. Whenever possible, authors of the original… CONTINUE READING
39 Citations
26 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues, Fourth Edition

  • S Swerdlow, E Campo, N Harris
  • 2008

Similar Papers

Loading similar papers…